Evangelia Peponi

572 total citations
20 papers, 448 citations indexed

About

Evangelia Peponi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Evangelia Peponi has authored 20 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Evangelia Peponi's work include Head and Neck Cancer Studies (5 papers), Glioma Diagnosis and Treatment (3 papers) and Head and Neck Surgical Oncology (3 papers). Evangelia Peponi is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Glioma Diagnosis and Treatment (3 papers) and Head and Neck Surgical Oncology (3 papers). Evangelia Peponi collaborates with scholars based in Greece, Switzerland and United States. Evangelia Peponi's co-authors include Gabriela Studer, Christoph Glanzmann, Gerhard Huber, Guadalupe Reyes, L. Jeffrey Medeiros, Ηλίας Δράκος, George Z. Rassidakis, Vasiliki Leventaki, Kalitsa Filioussi and Stefanos Bonovas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and American Journal Of Pathology.

In The Last Decade

Evangelia Peponi

19 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evangelia Peponi Greece 9 157 145 99 87 74 20 448
Howard Liu Australia 13 198 1.3× 109 0.8× 124 1.3× 202 2.3× 116 1.6× 43 555
Yunming Tian China 14 127 0.8× 279 1.9× 198 2.0× 198 2.3× 163 2.2× 24 677
S.N. Powell United States 8 99 0.6× 251 1.7× 30 0.3× 261 3.0× 211 2.9× 25 604
Xinqiong Huang China 11 45 0.3× 171 1.2× 62 0.6× 111 1.3× 40 0.5× 18 347
Peter W. Nagle Netherlands 11 88 0.6× 140 1.0× 12 0.1× 174 2.0× 38 0.5× 16 450
Katharine A. Price United States 10 265 1.7× 162 1.1× 104 1.1× 304 3.5× 136 1.8× 26 558
Y. Takai Japan 12 149 0.9× 173 1.2× 7 0.1× 120 1.4× 50 0.7× 47 481
Belma Kurdoglu United States 8 65 0.4× 147 1.0× 10 0.1× 200 2.3× 49 0.7× 9 468
Glenda Y. Ross United States 14 193 1.2× 129 0.9× 9 0.1× 96 1.1× 44 0.6× 21 476
Zhiqiang Mo China 10 68 0.4× 246 1.7× 11 0.1× 153 1.8× 61 0.8× 23 466

Countries citing papers authored by Evangelia Peponi

Since Specialization
Citations

This map shows the geographic impact of Evangelia Peponi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelia Peponi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelia Peponi more than expected).

Fields of papers citing papers by Evangelia Peponi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelia Peponi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelia Peponi. The network helps show where Evangelia Peponi may publish in the future.

Co-authorship network of co-authors of Evangelia Peponi

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelia Peponi. A scholar is included among the top collaborators of Evangelia Peponi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelia Peponi. Evangelia Peponi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peponi, Evangelia, et al.. (2021). ICAM-1 expression in patients with advanced non-small cell lung cancer treated with radiotherapy.. PubMed. 25(4). 1779–1783. 4 indexed citations
2.
Mauri, Davide, George Zarkavelis, Nikolaos P. Polyzos, et al.. (2019). Global coverage and consistency of guideline recommendations for cancer cachexia on the Web in 2011 and 2018. Współczesna Onkologia. 23(2). 100–109. 2 indexed citations
3.
Alexiou, George Α., Konstantinos I. Tsamis, Evangelia Peponi, et al.. (2019). Combination treatment for glioblastoma with temozolomide, DFMO and radiation.. PubMed. 24(1). 397–404. 18 indexed citations
4.
Peponi, Evangelia, et al.. (2019). E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy. In Vivo. 34(1). 453–459. 4 indexed citations
5.
Peponi, Evangelia, et al.. (2015). Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety. Gastroenterology Research. 8(6). 303–308. 3 indexed citations
6.
Alexiou, George Α., Konstantinos I. Tsamis, Evangelia Peponi, et al.. (2015). Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells. Journal of Neuro-Oncology. 123(2). 217–224. 23 indexed citations
7.
Peponi, Evangelia, et al.. (2015). 3D conformal radiotherapy in primary nasopharyngeal cancer: effectiveness and prognostic factors.. PubMed. 20(2). 514–20. 3 indexed citations
8.
Peponi, Evangelia, et al.. (2014). Prognostic factors in glioblastoma patients managed with radiotherapy combined with temozolomide.. PubMed. 19(3). 718–23. 3 indexed citations
9.
Peponi, Evangelia, et al.. (2014). Pharmacogenetics in Pancreatic Cancer. PubMed. 15(4). 335–9.
10.
Peponi, Evangelia, et al.. (2013). Intraoperative electron beam radiotherapy followed by moderate doses of external beam radiotherapy in the treatment of resected soft tissue sarcomas of the extremities.. PubMed. 9(4). 391–8. 2 indexed citations
11.
Peponi, Evangelia, et al.. (2013). The Role of Leptin in Cancer Pathogenesis. Journal of Cancer Therapy. 4(2). 640–650. 5 indexed citations
12.
Peponi, Evangelia, et al.. (2012). Reirradiation for recurrent head and neck carcinoma.. PubMed. 17(3). 465–70. 3 indexed citations
13.
Peponi, Evangelia, et al.. (2011). Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiation Oncology. 6(1). 1–1. 153 indexed citations
14.
Peponi, Evangelia, et al.. (2011). Pure Small Cell Carcinoma of the Prostate: A Case Report and Literature Review. SHILAP Revista de lepidopterología. 4(1). 88–95. 14 indexed citations
15.
Studer, Gabriela, et al.. (2010). Surviving Hypopharynx–Larynx Carcinoma in the Era of IMRT. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1391–1396. 30 indexed citations
16.
Peponi, Evangelia, et al.. (2010). Simultaneous Integrated Boost Intensity‑Modulated Radiotherapy (SIB‑IMRT) in Nasopharyngeal Cancer. Strahlentherapie und Onkologie. 186(3). 135–142. 24 indexed citations
17.
Bonovas, Stefanos, Georgios K. Nikolopoulos, Kalitsa Filioussi, et al.. (2009). Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials. European Journal of Epidemiology. 25(1). 29–35. 36 indexed citations
18.
Peponi, Evangelia, Ηλίας Δράκος, Guadalupe Reyes, et al.. (2006). Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma. American Journal Of Pathology. 169(6). 2171–2180. 98 indexed citations
19.
Peponi, Evangelia, et al.. (2005). Inhibition of AKT/mTOR Signaling Induces Cell Cycle Arrest and Apoptosis in Mantle Cell Lymphoma.. Blood. 106(11). 2415–2415. 3 indexed citations
20.
Peponis, Vasileios, Stefanos Bonovas, Evangelia Peponi, et al.. (2004). Conjunctival and tear film changes after vitamin C and E administration in non-insulin dependent diabetes mellitus.. PubMed. 10(5). CR213–7. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026